Progress and challenges for a ME/CFS diagnosis - Prof Ron Davis and Janet Dafoe

Progress and Challenges for a Myalgic Encephalomyelitis / Chronic Fatigue Syndrome Diagnosis with Prof Ron Davis and Janet Dafoe Abstract: A significant portion of the Stanford Genome Technology Center’s advanced technologies are being focused on myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS), which afflicts up to an estimated approximately two million people in the United States. There is currently no biological test to diagnose ME/CFS and as a result, diagnosing ME/CFS patients is a lengthy and costly process, constituting a fundamental impediment to patient care. This lag in diagnosis also erects barriers to research, complicating patient recruitment for clinical trials of new treatments. To remedy this situation, the SGTC is pioneering several areas of research on ME/CFS in order to search for a cause and establish a diagnostic that can be rapidly disseminated. About Ron: Ronald W. Davis, Ph.D., is Professor of Biochemistry and of Genetics at Stanford University School of Medicine, Director of the Stanford Genome Technology Center, and Director of the Chronic Fatigue Syndrome Research Center at Stanford University. Dr. Davis is a member of the National Academy of Sciences. Throughout his career he has made numerous seminal discoveries that have accelerated genetics, genomics, and bioengineering, including over 70 patented technologies that have launched numerous successful companies. His contributions have been recognized by the Gruber Genetics Prize, the Genetics Society of America Medal, the Warren Alpert Prize, and the Personalized Medicine World Conference Luminary Award. In 2013, he was named one of the 7 World’s Greatest Inventors by The Atlantic. He now is devoted to finding a cure for ME/CFS. This amazing event was hosted by Sheffield ME and Fibromyalgia Group, celebrating its 20th year as a registered charity. Find more information about the Group and its activities on https://www.sheffieldmegroup.co.uk/